Ethosuximide Capsules — Class II drug recall D-1183-2018
Terminated recall by Akorn, Inc., reported 2018-09-12, distributed nationwide. Failed Impurities/Degradation Specifications: Out of specification (OOS) results for unspecified impurity.
| Recall number | D-1183-2018 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Akorn, Inc., Lake Forest, IL, United States |
| Recall initiated | 2018-08-24 |
| Classified | 2018-09-07 |
| Reported by FDA | 2018-09-12 |
| Terminated | 2020-11-06 |
| Distributed | Nationwide (US) |
| Reason classes | specification failure |
| NDC | 61748-0025-01 |
| Lot numbers | 1165280100, 1165280101 |
| Expiration dates | 2019-03 |
Product
Ethosuximide Capsules, USP, 250 mg, 100 capsules per bottle, Rx only, Mfg For VersaPharm Incorporated, Maroerre, GA 30062. Mfg By: Swiss Caps AG, Kirchberg, Switzerland. NDC: 61748-025-01
Reason for recall
Failed Impurities/Degradation Specifications: Out of specification (OOS) results for unspecified impurity.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1183-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.